Actively Recruiting
Study of Different Antibiotics for Treating Asymptomatic Congenital Syphilis in Newborns Using Oral and Injection Methods
Led by London School of Hygiene and Tropical Medicine · Updated on 2026-10-22
90
Participants Needed
3
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the use of different antibiotic treatments for newborns with all-risk asymptomatic congenital syphilis, a condition passed from mother to baby during pregnancy. This phase II study aims to evaluate the safety and how the body processes these antibiotics in newborns, comparing three different treatment options. The treatments being evaluated include a 10-day course of oral Linezolid given twice daily, a 10-day course of oral Amoxicillin given twice daily, and a single intramuscular injection of Benzathine Penicillin G. Participants are randomly assigned to one of these three treatment groups to compare their effects. During the study, newborns will be closely monitored from enrollment through 10 days of treatment, with assessments including blood and cerebrospinal fluid antibiotic levels and tracking any adverse events up to 24 weeks. Researchers will also evaluate clinical outcomes over this period. The total participation may last up to 24 weeks to ensure safety and effectiveness monitoring.
CONDITIONS
Brief Title
Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis
Research Team
S
Sarah Prentice
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here